Allison DeAngelis and Damian Garde

BioTech

Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus

Will we ever get an HIV vaccine? And is the oft-criticized institution that awards the Nobel Prize each year showing signs of evolution? We cover

Allison DeAngelis and Damian Garde October 5, 2023

BioTech

What ever happened to biotech’s big comeback?

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates

Allison DeAngelis and Damian Garde September 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Allison DeAngelis and Damian Garde

Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus

What ever happened to biotech’s big comeback?

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe